Croatia Cannabis & Hemp News

Top Countries

09/27/2017 - 9:31am
PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia
(Australia, Canada, Cannabis, CBD, Consulting, Croatia, Development, Education, Events, Facilities, Germany, Investing, Investments, Kosovo, Management, Manufacture, Manufacturing, Medical Marijuana, News, Processing, Production, Products, Recreational, Regulations, Research, Tracking, United States, Recreational Cannabis, Cultivation, Funding, Real Estate, Security) PUF Ventures (CSE: PUF , Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The agreement is between the Richmond Valley Council and PUF Ventures Australia (“PVA“), a recently formed, majority owned subsidiary of the Company, which shall be led by Mr. Michael Horsfall of Sydney, New South Wales, Australia as President and CEO. At full scale, the new facility will have the capacity to support annual production of 100,000 kilograms of high quality cannabis, which equates to an associated annual revenue generation potential of between C$800 million and C$1.1 billion (based on current...
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabi...
09/27/2017 - 9:31am
PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia
(Australia, Canada, Cannabis, CBD, Consulting, Croatia, Development, Education, Events, Facilities, Germany, Investing, Investments, Kosovo, Management, Manufacture, Manufacturing, Medical Marijuana, News, Processing, Production, Products, Recreational, Regulations, Research, Tracking, United States, Recreational Cannabis, Cultivation, Funding, Real Estate, Security) PUF Ventures (CSE: PUF , Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The agreement is between the Richmond Valley Council and PUF Ventures Australia (“PVA“), a recently formed, majority owned subsidiary of the Company, which shall be led by Mr. Michael Horsfall of Sydney, New South Wales, Australia as President and CEO. At full scale, the new facility will have the capacity to support annual production of 100,000 kilograms of high quality cannabis, which equates to an associated annual revenue generation potential of between C$800 million and C$1.1 billion (based on current...
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabi...
09/27/2017 - 9:31am
PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia
(Australia, Canada, Cannabis, CBD, Consulting, Croatia, Development, Education, Events, Facilities, Germany, Investing, Investments, Kosovo, Management, Manufacture, Manufacturing, Medical Marijuana, News, Processing, Production, Products, Recreational, Regulations, Research, Tracking, United States, Recreational Cannabis, Cultivation, Funding, Real Estate, Security) PUF Ventures (CSE: PUF , Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The agreement is between the Richmond Valley Council and PUF Ventures Australia (“PVA“), a recently formed, majority owned subsidiary of the Company, which shall be led by Mr. Michael Horsfall of Sydney, New South Wales, Australia as President and CEO. At full scale, the new facility will have the capacity to support annual production of 100,000 kilograms of high quality cannabis, which equates to an associated annual revenue generation potential of between C$800 million and C$1.1 billion (based on current...
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabi...
09/27/2017 - 9:31am
PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia
(Australia, Canada, Cannabis, CBD, Consulting, Croatia, Development, Education, Events, Facilities, Germany, Investing, Investments, Kosovo, Management, Manufacture, Manufacturing, Medical Marijuana, News, Processing, Production, Products, Recreational, Regulations, Research, Tracking, United States, Recreational Cannabis, Cultivation, Funding, Real Estate, Security) PUF Ventures (CSE: PUF , Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The agreement is between the Richmond Valley Council and PUF Ventures Australia (“PVA“), a recently formed, majority owned subsidiary of the Company, which shall be led by Mr. Michael Horsfall of Sydney, New South Wales, Australia as President and CEO. At full scale, the new facility will have the capacity to support annual production of 100,000 kilograms of high quality cannabis, which equates to an associated annual revenue generation potential of between C$800 million and C$1.1 billion (based on current...
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabi...
09/27/2017 - 9:31am
PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia
(Australia, Canada, Cannabis, CBD, Consulting, Croatia, Development, Education, Events, Facilities, Germany, Investing, Investments, Kosovo, Management, Manufacture, Manufacturing, Medical Marijuana, News, Processing, Production, Products, Recreational, Regulations, Research, Tracking, United States, Recreational Cannabis, Cultivation, Funding, Real Estate, Security) PUF Ventures (CSE: PUF , Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The agreement is between the Richmond Valley Council and PUF Ventures Australia (“PVA“), a recently formed, majority owned subsidiary of the Company, which shall be led by Mr. Michael Horsfall of Sydney, New South Wales, Australia as President and CEO. At full scale, the new facility will have the capacity to support annual production of 100,000 kilograms of high quality cannabis, which equates to an associated annual revenue generation potential of between C$800 million and C$1.1 billion (based on current...
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabi...
09/27/2017 - 9:31am
PUF Ventures to Build 1 Million-Square-Foot Cannabis Cultivation and Processing Facility in Australia
(Australia, Canada, Cannabis, CBD, Consulting, Croatia, Development, Education, Events, Facilities, Germany, Investing, Investments, Kosovo, Management, Manufacture, Manufacturing, Medical Marijuana, News, Processing, Production, Products, Recreational, Regulations, Research, Tracking, United States, Recreational Cannabis, Cultivation, Funding, Real Estate, Security) PUF Ventures (CSE: PUF , Frankfurt:PU3, OTCPK:PUFXF), is pleased to announce that it has agreed to a strategic partnership with the Richmond Valley Council, the local government in the Northern Rivers region of northeastern New South Wales, Australia, to construct a 1 million-square-foot greenhouse operation, with large scale manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The agreement is between the Richmond Valley Council and PUF Ventures Australia (“PVA“), a recently formed, majority owned subsidiary of the Company, which shall be led by Mr. Michael Horsfall of Sydney, New South Wales, Australia as President and CEO. At full scale, the new facility will have the capacity to support annual production of 100,000 kilograms of high quality cannabis, which equates to an associated annual revenue generation potential of between C$800 million and C$1.1 billion (based on current...
https://investingnews.com/daily/resource-investing/agriculture-investing/cannabi...
06/20/2017 - 1:10pm
Erin Resources Limited ASX:ERI
Australian medical cannabis firm targets Balkans
(ASX:ERI, Australia, Cannabis, Croatia, Distribution, Erin Resources Limited, Extraction, Medical Marijuana, News, Products, Slovenia, Pharmaceuticals, Cultivation) A medical cannabis company in Perth, Australia, has signed a distribution agreement with a Slovenian company to expand the MMJ market in Europe. Under the deal, Australia-based MGC Pharmaceuticals will grow and process cannabis at its cultivation and extraction sites in Europe and then wholesale the products to Mikro+Polo, according to the Business News of Western Australia. In turn, Mikro – based in Maribor, Slovenia – will distribute MGC’s medical cannabis products in Slovenia, Croatia and ... Australian medical cannabis firm targets Balkans is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
https://mjbizdaily.com/australian-medical-cannabis-firm-targets-balkans/
06/20/2017 - 1:10pm
Erin Resources Limited ASX:ERI
Australian medical cannabis firm targets Balkans
(ASX:ERI, Australia, Cannabis, Croatia, Distribution, Erin Resources Limited, Extraction, Medical Marijuana, News, Products, Slovenia, Pharmaceuticals, Cultivation) A medical cannabis company in Perth, Australia, has signed a distribution agreement with a Slovenian company to expand the MMJ market in Europe. Under the deal, Australia-based MGC Pharmaceuticals will grow and process cannabis at its cultivation and extraction sites in Europe and then wholesale the products to Mikro+Polo, according to the Business News of Western Australia. In turn, Mikro – based in Maribor, Slovenia – will distribute MGC’s medical cannabis products in Slovenia, Croatia and ... Australian medical cannabis firm targets Balkans is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
https://mjbizdaily.com/australian-medical-cannabis-firm-targets-balkans/
06/20/2017 - 1:10pm
Erin Resources Limited ASX:ERI
Australian medical cannabis firm targets Balkans
(ASX:ERI, Australia, Cannabis, Croatia, Distribution, Erin Resources Limited, Extraction, Medical Marijuana, News, Products, Slovenia, Pharmaceuticals, Cultivation) A medical cannabis company in Perth, Australia, has signed a distribution agreement with a Slovenian company to expand the MMJ market in Europe. Under the deal, Australia-based MGC Pharmaceuticals will grow and process cannabis at its cultivation and extraction sites in Europe and then wholesale the products to Mikro+Polo, according to the Business News of Western Australia. In turn, Mikro – based in Maribor, Slovenia – will distribute MGC’s medical cannabis products in Slovenia, Croatia and ... Australian medical cannabis firm targets Balkans is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
https://mjbizdaily.com/australian-medical-cannabis-firm-targets-balkans/
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
03/24/2017 - 2:27pm
Invictus MD Strategies Corp. IVITF
Invictus MD Strategies Appoints George E. Kveton to Board of Directors.
(Acquisitions, Biotechnology, Canada, Cannabis, Consumer Goods, Croatia, Deals, Development, Fertilizer, Hungary, Investing, Investment, Investors, Invictus MD Strategies Corp., IVITF, Japan, Management, News, Poland, Production, Products, Science, Switzerland, Tobacco, United States) Invictus MD (CNX: IMH ) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries. He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies...
http://investingnews.com/daily/resource-investing/agriculture-investing/cannabis...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
08/08/2016 - 8:00am
GW Pharmaceuticals plc, Bedrocan Cannabis Corp., AbbVie Inc., Valeant Pharmaceuticals Intl. ABBV, BNRDF, GWPH, VRX
The Situation With Medicinal Cannabis In Europe – A Complete Overview
(ABBV, AbbVie Inc., Andorra, Austria, Bedrocan Cannabis Corp., Belgium, BNRDF, Bulgaria, Cannabis, CBD, Croatia, Czech Republic, Denmark, Distribution, Distributor, Finland, France, Germany, Greece, Grower, Growers, Growing, GW Pharmaceuticals plc, GWPH, Hemp, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Manufacture, Manufacturer, Marketing, Media, Medical Marijuana, Monaco, Netherlands, News, Norway, Organic, Poland, Portugal, Production, Products, Russia, San Marino, Serbia, Slovenia, Spain, Strains, Sweden, Switzerland, Synthetic, Valeant Pharmaceuticals Intl., VRX, Synthetic Cannabinoids, THC, Pharmaceuticals, Cultivation) While there is plenty of accurate, up-to-date information online about medicinal cannabis in Europe, finding one reliable source to tell you everything you need to know can be an all-but-impossible task. So we’ve collated hundreds of online resources – news reports, analysis by governments and NGOs, and patient perspectives – in order to create a complete overview of the status of medicinal cannabis in Europe. We have striven for clarity and accuracy in all respects, but we recognise the fact that legislative waters can at times be murky and misinterpretations can be made. Added to this, legislation is changing rapidly, so we’ll be adding updates every three months or more if necessary. Thus, we welcome any comments, feedback, or corrections – and your input will help us to make this a truly interactive resource that will continue to be relevant for many years to come! Medicinal Cannabis Legality & Availability In Europe This map shows the general state of medicinal cannabis...
https://sensiseeds.com/en/blog/situation-medicinal-cannabis-europe-complete-over...
06/23/2016 - 11:22pm
Croatia Makes Medical Cannabis History. How Did It Happen?
(Cannabis, Croatia, Medical Marijuana) Most European countries, as well as many American states that have legalized medical cannabis in some form in recent years, have struggled to ...
https://www.leafly.com/news/headlines/croatia-makes-medical-cannabis-history-how...
06/11/2016 - 1:16pm
Canada's First Marijuana Export Permit Means Bud Bound For Croatia - Huffington Post Canada
(Canada, Cannabis, Croatia, Medical Marijuana, News, Products, Texas, United States) Huffington Post Canada Canada's First Marijuana Export Permit Means Bud Bound For Croatia Huffington Post CanadaTORONTO -- Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia. The company will be exporting two varieties of liquid capsules that contain the active ... They smell opportunity in Texas marijuana 'green rush' nwitimes.com all 5 news articles »
http://www.huffingtonpost.ca/2016/06/11/marijuana-exports-canada_n_10416924.html
06/11/2016 - 1:16pm
Canada's First Marijuana Export Permit Means Bud Bound For Croatia - Huffington Post Canada
(Canada, Cannabis, Croatia, Medical Marijuana, News, Products, Texas, United States) Huffington Post Canada Canada's First Marijuana Export Permit Means Bud Bound For Croatia Huffington Post CanadaTORONTO -- Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia. The company will be exporting two varieties of liquid capsules that contain the active ... They smell opportunity in Texas marijuana 'green rush' nwitimes.com all 5 news articles »
http://www.huffingtonpost.ca/2016/06/11/marijuana-exports-canada_n_10416924.html
06/11/2016 - 1:16pm
Canada's First Marijuana Export Permit Means Bud Bound For Croatia - Huffington Post Canada
(Canada, Cannabis, Croatia, Medical Marijuana, News, Products, Texas, United States) Huffington Post Canada Canada's First Marijuana Export Permit Means Bud Bound For Croatia Huffington Post CanadaTORONTO -- Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia. The company will be exporting two varieties of liquid capsules that contain the active ... They smell opportunity in Texas marijuana 'green rush' nwitimes.com all 5 news articles »
http://www.huffingtonpost.ca/2016/06/11/marijuana-exports-canada_n_10416924.html
06/10/2016 - 10:00pm
Tilray Begins Exporting Medical Marijuana to Croatia
(Canada, Cannabis, Croatia, Medical Marijuana, Products) After being granted export permit by Health Canada, Tilray looks to global demand for cannabis products. Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia. The Vancouver Island-based company will be exporting two varieties of liquid capsules that contain the active medicinal ingredients of marijuana to patients in Croatia, which legalized the drug for medical use last year. - Read the… The post Tilray Begins Exporting Medical Marijuana to Croatia appeared first on Cannabis Culture .
http://www.cannabisculture.com/content/2016/06/10/tilray-begins-exporting-medica...